Latest News

Results from Genentech’s Evrysdi Study in Infants with Type 1 SMA Published in NEJM

February 25, 2021
Posted in , ,

Genentech, a member of the Roche Group, announced in a press release that Evrysdi™ (risdiplam) data from the dose finding Part 1 of the pivotal FIREFISH study in infants with […]

Read More ›

Cure SMA Launches Virtual Therapy Program for Adults with SMA

February 19, 2021
Posted in , ,

Adults with spinal muscular atrophy (SMA) are invited to take advantage of Cure SMA’s latest support resource, the Adults with SMA Virtual Therapy Program, which has been generously sponsored by […]

Read More ›

Community Spotlight: I Am…Kelsey Roberts

February 5, 2021
Posted in ,

February 28 is Rare Disease Day. Throughout the month—in recognition of our Redefining Rare initiative — we will be posting stories about SMA community members, showcasing their greatest passions, hobbies […]

Read More ›

Cure SMA Coronavirus (COVID-19) Information Center

January 28, 2021
Posted in

Over the past year and a half, we hope that you have found this page to be a helpful resource as you navigated the COVID-19 pandemic. As we seek to […]

Read More ›

Cure SMA Career Panel Webinar Series to Launch in February

January 22, 2021
Posted in , ,

Cure SMA is excited to invite all members of the SMA community to join our new, three-part Career Panel Webinar Series, generously sponsored by Biogen. During these 1-hour webinars, adults […]

Read More ›

Cure SMA Announces 2021 Summit of Strength Program Events

January 20, 2021
Posted in , ,

Cure SMA is excited to share that we will be continuing the Summit of Strength Program in 2021, offering a hybrid of the original in-person events and the webinars launched […]

Read More ›
Scroll to Top